Publication
Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles
Downloadable Content
- Persistent URL
- Last modified
- 03/14/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2017-02-01
- Publisher
- Elsevier
- Publication Version
- Copyright Statement
- © 2016 Elsevier B.V.
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 0927-7765
- Volume
- 150
- Start Page
- 261
- End Page
- 270
- Grant/Funding Information
- This work is supported in parts by NIH R01CA154846-02 (HM and LY), NCI’s Cancer Nanotechnology Platform Project (CNPP) grant U01CA151810-02 (HM and LY), a seed grant from the Center for Pediatric Nanomedicine of Children’s Healthcare of Atlanta (HM and TM), and Oversea Study Program of Guangzhou Elite Project (GEP, 11YB18) (RL).
- Supplemental Material (URL)
- Abstract
- Detecting circulating tumor cells (CTCs) with high sensitivity and specificity is critical to management of metastatic cancers. Although immuno-magnetic technology for in vitro detection of CTCs has shown promising potential for clinical applications, the biofouling effect, i.e., non-specific adhesion of biomolecules and non-cancerous cells in complex biological samples to the surface of a device/probe, can reduce the sensitivity and specificity of cell detection. Reported herein is the application of anti-biofouling polyethylene glycol-block-allyl glycidyl ether copolymer (PEG-b-AGE) coated iron oxide nanoparticles (IONPs) to improve the separation of targeted tumor cells from aqueous phase in an external magnetic field. PEG-b-AGE coated IONPs conjugated with transferrin (Tf) exhibited significant anti-biofouling properties against non-specific protein adsorption and off-target cell uptake, thus substantially enhancing the ability to target and separate transferrin receptor (TfR) over-expressed D556 medulloblastoma cells. Tf conjugated PEG-b-AGE coated IONPs exhibited a high capture rate of targeted tumor cells (D556 medulloblastoma cell) in cell m edia (58.7 ± 6.4%) when separating 100 targeted tumor cells from 1 × 10 5 non-targeted cells and 41 targeted tumor cells from 100 D556 medulloblastoma cells spiked into 1 mL blood. It is demonstrated that developed nanoparticle has higher efficiency in capturing targeted cells than widely used micron-sized particles (i.e., Dynabeads ® ).
- Author Notes
- Keywords
- Biophysics
- BREAST-CANCER
- Circulating tumor cells
- ENRICHMENT
- LEUKEMIA B-CELLS
- TRANSFERRIN
- Physical Sciences
- RESISTANT PROSTATE-CANCER
- Anti-biofouling
- Life Sciences & Biomedicine
- IN-VITRO
- RECEPTOR
- Science & Technology
- Chemistry
- Chemistry, Physical
- Materials Science, Biomaterials
- Targeting
- SEPARATION
- Technology
- Cell separation
- Magnetic nanoparticles
- CIRCULATING TUMOR-CELLS
- Materials Science
- PERIPHERAL-BLOOD
- Research Categories
- Health Sciences, Radiology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - s7phd.pdf | Primary Content | 2025-03-08 | Public | Download |